- Home
- GIFI vs OBIO Comparison
GIFI vs OBIO Comparison
Compare GIFI & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIFI
- OBIO
- Stock Information
- Founded
- GIFI 1985
- OBIO 2017
- Country
- GIFI United States
- OBIO United States
- Employees
- GIFI N/A
- OBIO N/A
- Industry
- GIFI Metal Fabrications
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- GIFI Industrials
- OBIO Health Care
- Exchange
- GIFI Nasdaq
- OBIO Nasdaq
- Market Cap
- GIFI 111.5M
- OBIO 118.8M
- IPO Year
- GIFI 1997
- OBIO N/A
- Fundamental
- Price
- GIFI $6.79
- OBIO $2.55
- Analyst Decision
- GIFI
- OBIO Strong Buy
- Analyst Count
- GIFI 0
- OBIO 4
- Target Price
- GIFI N/A
- OBIO $14.67
- AVG Volume (30 Days)
- GIFI 24.2K
- OBIO 451.7K
- Earning Date
- GIFI 08-06-2025
- OBIO 08-12-2025
- Dividend Yield
- GIFI N/A
- OBIO N/A
- EPS Growth
- GIFI N/A
- OBIO N/A
- EPS
- GIFI 0.60
- OBIO N/A
- Revenue
- GIFI $152,867,000.00
- OBIO $2,944,000.00
- Revenue This Year
- GIFI N/A
- OBIO $19.83
- Revenue Next Year
- GIFI N/A
- OBIO $12.53
- P/E Ratio
- GIFI $11.30
- OBIO N/A
- Revenue Growth
- GIFI 14.32
- OBIO 41.61
- 52 Week Low
- GIFI $5.12
- OBIO $2.37
- 52 Week High
- GIFI $7.59
- OBIO $7.04
- Technical
- Relative Strength Index (RSI)
- GIFI 47.42
- OBIO 42.61
- Support Level
- GIFI $6.72
- OBIO $2.50
- Resistance Level
- GIFI $6.93
- OBIO $2.75
- Average True Range (ATR)
- GIFI 0.17
- OBIO 0.14
- MACD
- GIFI -0.01
- OBIO -0.01
- Stochastic Oscillator
- GIFI 50.00
- OBIO 42.50
About GIFI Gulf Island Fabrication Inc.
Gulf Island Fabrication Inc is a U.S. based company that is a fabricator of complex steel structures and marine vessels. The company also provides installation, hook-up, commissioning, repair, and maintenance services with specialized crews. The company operates through segments namely Fabrication division which fabricates structures such as offshore drilling and production platforms and other steel structures for customers in the oil and gas industries; the Shipyards division manufactures newly built and repairs various steel marine vessels in the United States; the Services division provides interconnect piping services on offshore platforms, welding, and inshore structures and also provides maintenance and industrial facilities. Majority revenue is from services segment.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.